BiotechTubeBiotechTube
Home/Cassava Sciences/Remi Barbier
RB

Remi Barbier

President, Chief Executive Officer, and Chairman of the Board

Cassava Sciences

Therapeutic Areas

Alzheimer's DiseaseNeurodegenerative Diseases

Cassava Sciences Pipeline

DrugIndicationPhase
Simufilam (PTI-125)Alzheimer's DiseasePhase 3
SavaDxAlzheimer's Disease (Diagnostic)Pre-clinical

Leadership Team at Cassava Sciences

EJ
Eric J. Schoen
Chief Financial Officer
JW
James W. Kupiec, M.D.
Chief Medical Officer
DR
David R. Gwynn, J.D.
Senior Vice President, General Counsel, and Corporate Secretary
LA
Lindsay A. Burns, Ph.D.
Senior Vice President of Neuroscience
SR
Sanford Robertson
Director
RB
Richard Barry
Director
PJ
Patrick J. McEnany
Director
View full Cassava Sciences profile